Plus therapeutics, inc. (CYTX)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
Assets
Current assets:
Cash and cash equivalents

16,061

17,552

16,834

4,530

3,872

5,261

6,806

3,079

5,902

9,550

4,783

9,028

6,255

12,560

14,924

20,042

9,358

14,338

18,970

23,842

13,199

14,622

7,849

12,760

12,800

15,506

10,205

13,621

16,404

25,717

17,628

25,771

34,399

36,922

40,803

33,229

52,668

Accounts receivable

978

1,169

4,781

80

455

178

440

399

769

145

230

807

873

1,242

918

911

829

1,052

1,134

750

704

1,243

532

2,004

3,636

4,152

2,622

2,897

2,961

3,926

1,463

1,983

1,425

2,260

1,967

2,461

2,073

Restricted cash

-

40

40

40

40

40

40

40

40

675

429

429

350

350

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventories, net

107

107

107

107

3,003

107

2,814

3,007

3,188

3,183

3,508

4,243

4,107

3,725

3,946

4,534

4,462

4,298

4,612

4,079

4,614

4,829

5,020

4,488

4,225

3,694

4,138

4,012

3,646

3,175

3,411

3,108

3,374

3,318

4,153

3,891

3,378

Other current assets

551

957

502

503

1,092

785

654

837

837

1,311

892

1,116

500

870

1,253

1,263

1,866

1,555

1,314

986

1,344

992

1,245

1,288

1,391

1,225

1,128

1,189

1,189

1,161

1,090

1,115

1,135

837

702

849

834

Current assets held for sale

-

-

-

-

-

3,277

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current assets

17,697

19,825

22,264

5,260

8,462

9,648

10,754

7,362

10,736

14,864

9,842

15,623

12,085

18,747

21,041

26,750

16,515

21,243

26,030

29,657

19,861

21,686

14,646

20,540

22,052

24,577

18,093

21,719

24,200

33,979

23,592

31,977

40,333

43,337

47,625

40,430

58,953

Property and equipment, net

2,096

2,179

2,209

2,297

2,607

2,299

2,648

2,763

2,907

3,052

3,308

3,387

3,611

1,157

1,292

1,380

1,523

1,631

1,734

1,860

1,778

1,583

1,571

1,290

1,192

1,054

1,550

2,043

2,049

2,174

2,242

2,255

2,367

1,711

1,788

1,923

1,684

Operating lease right-of-use assets

744

781

818

905

2,153

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

350

350

350

350

350

350

350

350

350

350

350

350

350

350

350

350

350

350

350

350

350

350

350

Investment in joint venture

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

37

85

122

164

200

250

306

357

459

Other assets

58

72

52

50

1,827

39

1,938

2,048

2,182

2,570

1,854

1,712

2,008

2,336

1,474

1,449

1,682

1,521

1,214

1,480

1,785

1,763

2,291

2,567

2,412

2,812

1,962

2,448

2,808

2,740

1,756

1,755

1,794

1,772

1,330

1,471

566

Noncurrent assets held for sale

-

-

-

-

-

11,633

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangibles, net

-

-

-

-

5,645

-

6,270

6,582

6,895

7,207

7,520

7,832

8,145

8,447

8,763

8,829

8,923

9,031

9,196

9,255

9,350

9,415

9,534

9,581

9,494

9,345

9,345

9,282

-

0

26

81

136

192

247

303

413

Goodwill

372

372

372

372

3,922

372

3,922

3,922

3,922

3,922

3,922

3,922

3,922

3,922

3,922

3,922

3,922

3,922

3,922

3,922

3,922

3,922

3,922

3,922

3,922

3,922

3,922

3,922

3,922

3,922

3,922

3,922

3,922

3,922

3,922

3,922

3,922

Total assets

20,967

23,229

25,715

8,884

24,616

23,991

25,532

22,677

26,642

31,615

26,446

32,476

29,771

34,609

36,842

42,680

32,915

37,698

42,446

46,524

37,046

38,719

32,314

38,250

39,422

42,060

35,222

39,764

33,366

43,250

32,010

40,504

49,102

51,534

55,568

48,756

66,347

Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable and accrued expenses

3,670

3,279

3,334

2,953

3,224

2,777

3,645

3,780

4,150

4,790

4,907

6,485

6,196

5,872

5,637

6,585

6,693

6,687

6,279

7,003

5,614

5,546

5,739

6,527

6,443

6,077

5,471

6,252

6,000

7,411

5,588

5,066

6,046

5,334

6,374

6,857

6,770

Operating lease liability

136

147

156

157

700

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Term loan obligations, net of discount

11,182

11,060

10,937

10,813

14,371

14,202

14,007

13,836

13,729

13,624

13,497

6,744

6,686

6,629

5,267

3,494

1,724

0

1,446

26

10,000

7,363

5,477

7,342

5,241

3,191

1,193

21

9,800

9,784

9,767

7,338

4,911

2,487

69

8,755

6,453

Current liabilities held for sale

-

-

-

-

-

580

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Joint venture purchase obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,267

1,750

1,725

2,192

3,088

3,008

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Termination fee obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

200

400

600

800

800

0

-

-

-

-

-

-

-

Puregraft divestiture obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

158

215

388

547

608

-

-

0

-

-

-

-

-

-

-

Joint Venture purchase obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,691

4,772

769

-

0

-

-

-

-

-

-

-

Total current liabilities

14,988

14,486

14,427

13,923

18,295

17,559

17,652

17,616

17,879

18,414

18,404

13,229

12,882

12,501

10,904

10,079

9,684

8,437

9,450

9,221

18,702

15,917

14,478

16,731

14,825

14,906

12,644

7,842

16,684

17,613

15,355

12,404

10,957

7,821

6,443

15,612

13,223

Deferred revenues

-

-

-

-

142

-

187

-

-

94

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other noncurrent liabilities

8

8

38

65

98

46

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Noncurrent operating lease liability

624

646

684

748

1,518

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenues, related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

638

1,107

1,107

3,520

3,520

4,281

4,281

5,512

Warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Deferred revenues

-

-

-

-

-

-

-

217

178

-

103

110

109

97

97

106

101

105

143

253

118

112

168

212

206

212

190

235

232

2,635

5,147

5,296

5,176

5,244

5,118

4,964

4,929

Joint Venture purchase obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,817

2,647

2,553

-

-

-

-

-

-

-

-

-

-

-

-

Warrant liabilities, long-term

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12,527

18,187

25,237

-

287

-

-

-

0

0

84

418

-

-

-

0

-

-

-

Warrant liability, long-term

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,871

1,008

757

627

1,273

2,809

4,987

Option liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

2,500

2,250

2,400

2,100

1,640

1,910

1,850

1,280

1,170

Long-term deferred rent and other

-

-

-

-

-

-

83

93

105

107

120

136

17

17

41

111

189

269

348

419

507

558

629

613

664

710

754

784

988

756

684

600

498

504

468

374

398

Warrant liability

5,262

6,929

10,406

424

706

916

1,472

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9,793

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Noncurrent liabilities held for sale

-

-

-

-

-

245

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Joint Venture purchase obligation, less current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,921

-

-

-

-

-

-

-

-

-

Long-term obligations, net of discount, less current portion

-

-

-

-

-

-

-

-

-

-

0

7,771

9,400

11,008

12,130

13,663

15,198

16,681

14,978

16,184

15,677

18,041

20,332

19,501

21,325

23,100

24,822

25,719

10,594

12,903

15,178

17,441

19,704

21,962

24,209

9,295

13,255

Total liabilities

20,882

22,069

25,555

15,160

20,759

18,766

19,394

17,926

18,162

18,615

18,627

21,246

22,408

23,623

23,172

23,959

25,172

25,492

37,446

44,264

60,241

44,421

35,607

37,057

37,020

38,928

38,410

38,501

30,998

36,795

41,742

39,956

42,252

41,588

43,642

38,615

43,474

Commitments and contingencies (Notes 9)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

0

Stockholders’ equity:
Preferred stock, $0.001 par value; 5,000,000 shares authorized; 1,959 shares issued and outstanding at March 31, 2020 and December 31, 2019

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, $0.001 par value; 100,000,000 shares authorized; 3,880,588 shares issued and outstanding at March 31, 2020 and December 31, 2019

4

4

3

-

22

-

67

62

62

6

35

33

24

22

20

20

13

13

159

151

114

99

83

79

75

71

67

67

67

66

59

59

58

57

55

52

52

Additional paid-in capital

426,438

426,426

426,311

420,404

420,290

418,390

417,036

413,269

413,470

413,356

404,047

402,670

392,748

388,769

387,119

386,845

369,339

368,214

358,035

356,940

336,186

331,772

328,684

323,848

313,426

303,710

287,752

286,835

284,806

281,117

261,113

260,146

258,566

252,338

247,413

237,296

232,819

Accumulated other comprehensive income

-

-

-

-

1,078

1,218

1,182

1,237

1,106

1,387

1,199

1,183

1,198

1,258

675

617

747

996

1,061

951

736

700

457

399

206

256

-142

-34

-110

0

-

-

-

-

-

-

-

Accumulated deficit

-426,357

-425,270

-426,154

-426,680

-417,533

-414,383

-412,147

-409,817

-406,158

-401,749

-397,462

-392,656

-386,607

-379,063

-374,144

-368,761

-362,356

-357,017

-354,255

-355,782

-360,231

-338,273

-332,517

-323,133

-311,305

-300,905

-290,865

-285,605

-282,395

-274,728

-270,904

-259,657

-251,774

-242,449

-235,542

-227,207

-209,998

Total stockholders’ equity

85

1,160

160

-6,276

3,857

5,225

6,138

4,751

8,480

13,000

7,819

11,230

7,363

10,986

13,670

18,721

7,743

12,206

5,000

2,260

-23,195

-5,702

-3,293

1,193

2,402

3,132

-3,188

1,263

2,368

6,455

-9,732

548

6,850

9,946

11,926

10,141

22,873

Total liabilities and stockholders’ equity

20,967

23,229

25,715

8,884

24,616

23,991

25,532

22,677

26,642

31,615

26,446

32,476

29,771

34,609

36,842

42,680

32,915

37,698

42,446

46,524

37,046

38,719

32,314

38,250

39,422

42,060

35,222

39,764

33,366

43,250

32,010

40,504

49,102

51,534

55,568

48,756

66,347